Alector, Inc. Income Taxes Disclosure
9. Income Taxes
The federal and state income tax provision for the year ended December 31, 2025 and 2024 are summarized as follows (in thousands):
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Current: |
|
|
|
|
|
|
||
Federal |
|
$ |
— |
|
|
$ |
— |
|
State |
|
|
168 |
|
|
|
128 |
|
Income tax provision |
|
$ |
168 |
|
|
$ |
128 |
|
A reconciliation of the federal statutory rate to the Company’s effective tax rate is as follows for the years ended December 31, 2025 and 2024 (in thousands):
|
|
Year Ended December 31, |
|
|||||||||||
|
|
2025 |
|
|
2024 |
|
||||||||
US Federal Tax at Statutory Rate |
|
$ |
(29,980 |
) |
|
21.00 |
% |
|
$ |
(24,979 |
) |
|
21.00 |
% |
State and Local Effects (A) |
|
|
(34 |
) |
|
0.02 |
% |
|
|
(51 |
) |
|
0.04 |
% |
Tax credits |
|
|
|
|
|
|
|
|
|
|
||||
Research and Development Credit |
|
|
(1,634 |
) |
|
1.14 |
% |
|
|
(5,845 |
) |
|
4.91 |
% |
Orphan Drug Credit |
|
|
(1,705 |
) |
|
1.19 |
% |
|
|
— |
|
|
0.00 |
% |
Changes in valuation allowance |
|
|
27,140 |
|
|
(19.01 |
%) |
|
|
24,914 |
|
|
(20.95 |
%) |
Nontaxable or Nondeductible Items |
|
|
|
|
|
|
|
|
|
|
||||
Stock-based compensation (B) |
|
|
6,136 |
|
|
(4.30 |
%) |
|
|
5,372 |
|
|
(4.52 |
%) |
Other |
|
|
40 |
|
|
(0.02 |
%) |
|
|
84 |
|
|
(0.06 |
%) |
Changes in Unrecognized Tax Benefits |
|
|
205 |
|
|
(0.14 |
%) |
|
|
175 |
|
|
(0.15 |
%) |
Other |
|
|
— |
|
|
0.00 |
% |
|
|
458 |
|
|
(0.38 |
%) |
Income tax provision |
|
$ |
168 |
|
|
(0.12 |
%) |
|
$ |
128 |
|
|
(0.11 |
%) |
(A) For tax year 2025 and 2024, state taxes in California made up the majority (greater than 50 percent) of the tax effect in this category.
(B) Included in stock-based compensation is the reversal of incentive stock options and employee stock purchase plan expenses, shortfalls related to share based compensation, and non-deductible executive compensation under IRC §162(m).
Net cash paid (refunds received) for income taxes consisted of the following (in thousands):
|
|
|
Year Ended December 31, |
|
|
|||||
|
|
|
2025 |
|
|
2024 |
|
|
||
|
Federal |
|
$ |
(822 |
) |
|
$ |
— |
|
|
|
State and local jurisdiction |
|
|
(58 |
) |
|
|
(100 |
) |
|
CA |
California |
|
|
— |
|
* |
|
(59 |
) |
|
CO |
Colorado |
|
|
— |
|
* |
|
(9 |
) |
|
IL |
Illinois |
|
|
— |
|
* |
|
(7 |
) |
|
MI |
Michigan |
|
|
— |
|
* |
|
(10 |
) |
|
NC |
North Carolina |
|
|
— |
|
* |
|
(16 |
) |
|
OR |
Oregon |
|
|
— |
|
* |
|
(17 |
) |
|
|
Other States |
|
|
(58 |
) |
|
|
18 |
|
|
|
Net cash paid (refunds received) for income taxes |
|
$ |
(880 |
) |
|
$ |
(100 |
) |
|
|
|
|
|
|
|
|
|
|
||
|
*The amount of income taxes paid during the year does not meet the 5% disaggregation threshold and is included in “Other.” |
|
|
|||||||
The tax effects of temporary differences that give rise to significant components of the Company’s deferred tax assets and liabilities consist of (in thousands):
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Net operating loss |
|
$ |
106,407 |
|
|
$ |
36,843 |
|
Accrued bonus |
|
|
1,241 |
|
|
|
2,465 |
|
Tax credits |
|
|
39,433 |
|
|
|
34,373 |
|
Stock-based compensation |
|
|
14,086 |
|
|
|
15,456 |
|
Deferred revenue |
|
|
41,670 |
|
|
|
46,085 |
|
Lease liability |
|
|
6,460 |
|
|
|
7,796 |
|
Section 174 R&D capitalization |
|
|
66,824 |
|
|
|
81,291 |
|
Refund liability |
|
|
2,786 |
|
|
|
13,628 |
|
Other |
|
|
1,276 |
|
|
|
1,619 |
|
Gross deferred tax assets |
|
|
280,183 |
|
|
|
239,556 |
|
Less valuation allowance |
|
|
(274,229 |
) |
|
|
(231,296 |
) |
Total deferred tax assets |
|
$ |
5,954 |
|
|
$ |
8,260 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
$ |
(2,616 |
) |
|
$ |
(3,565 |
) |
Right-of-use assets |
|
|
(3,338 |
) |
|
|
(4,695 |
) |
Gross deferred tax liabilities |
|
|
(5,954 |
) |
|
|
(8,260 |
) |
Deferred tax assets, net |
|
$ |
— |
|
|
$ |
— |
|
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred assets will be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Evaluating the need for a valuation allowance for deferred tax assets often requires judgment and analysis of all the positive and negative evidence available, including cumulative losses in recent years and projected future taxable income, to determine whether all or some portion of the deferred tax assets will not be realized. As of December 31, 2025, the Company has utilized a full valuation allowance to offset the net deferred tax assets as the Company believes it is not more likely than not that the net deferred tax assets will be fully realizable. The valuation allowance for deferred tax assets increased by $42.9 million during the year ended December 31, 2025.
As of December 31, 2025, the Company had federal and state net operating loss (NOL) carryforwards of approximately $375.6 million and $419.1 million, respectively. Federal NOL carryforwards have an indefinite life and deductions cannot exceed 80% of taxable income. State NOL carryforwards will begin to expire as early as 2030, if not utilized, or have an indefinite life. As of December 31, 2025, the Company also had federal and California tax credit carryforward of approximately $39.4 million and $25.3 million, respectively. The federal tax credits will begin to expire in 2041 while the California tax credits have no expiration date.
Generally, utilization of the NOL carryforwards and credits may be subject to an annual limitation due to the ownership change limitations provided by Section 382, which provides for limitations on NOL carryforwards and certain built-in losses following ownership changes, and Section 383, which provides for special limitations on certain excess credits, etc., of the Code, and similar state provisions. Accordingly, the Company’s ability to utilize NOL carryforwards may be limited as the result of such an “ownership change.” The carryforwards could be subject to an annual limitation, resulting in a reduction in the gross deferred tax assets before considering the valuation allowance. Further, a portion of the carryforwards may expire before being applied to reduce future earnings. The Company is not aware of any changes in ownership that would result in material limitations under Section 382 at this time.
The following table summarizes the activity related to the Company’s unrecognized tax benefits for the years ended December 31, 2025 and 2024 (in thousands):
Balance as of December 31, 2023 |
|
$ |
20,204 |
|
Increase related to tax positions taken during the |
|
|
11 |
|
Increases related to tax positions taken during the |
|
|
2,710 |
|
Balance as of December 31, 2024 |
|
|
22,925 |
|
Increases related to tax positions taken during the |
|
|
1,839 |
|
Balance as of December 31, 2025 |
|
$ |
24,764 |
|
If the unrecognized tax benefits for uncertain tax positions as of December 31, 2025, is recognized, there will be no impact to the effective tax rate as the tax benefit would increase the net deferred tax assets, which is currently offset with a full valuation allowance. The Company’s policy is to include interest and penalties related to unrecognized tax benefits, if any, within the provision for taxes in the consolidated statements of operations. The Company accrued interest and penalties of $0.2 million for the year ended December 31, 2025 and of $0.2 million for the year ended December 31, 2024.
The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that the position is sustainable upon examination by the taxing authority, based on the technical merits. During the years ended December 31, 2025 and 2024, the Company recorded an uncertain tax position of $1.8 million and $2.7 million, respectively. The income tax provision for the years ended December 31, 2025 included changes to reserves related to prior year uncertain tax provisions of an increase of zero and decrease of zero, respectively. The income tax provision for the years ended December 31, 2024 included changes to reserves related to prior year uncertain tax provisions of an increase of less than $0.1 million and decrease of zero. The Company’s income tax returns generally remain subject to examination by federal and most state tax authorities.
The Company is currently not subject to any federal income tax audits by the IRS but is subject to ongoing tax audits in various state jurisdictions. The statute of limitations for tax liabilities for all years remains open.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 26, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Mar 24, 2020 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.